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Background: This study was aimed at determining the prevalence and type of hearing disorders 
in HIV positive patients and any correlationship with the CD4 counts/stage of HIV/AIDS in 
patients attending the comprehensive care clinic (CCC).                                                                                                    
Methods: Case control study of 194 HIV positive patients attending CCC recruited into the 
study after informed consent. A thorough clinical examination and otoscopy done followed by 
tuning fork tests, Pure Tone Audiometry and tympanometric tests. This was compared with 124 
HIV negative subjects matched for age and sex who were recruited from the voluntary 
counseling and testing centre. The world health organization staging of the HIV/AIDS disease 
and the CD4 positive lymphocyte cell count were carried out and correlated with any hearing 
disorder. Results were analyzed using statistical package for social sciences version 10.0.                                                                 
Results: Hearing loss (HL) was present in 33.5% of HIV positve compared to 8.1% in negative 
subjects. No gender bias in HL but HL worsened with advancement of age. SNHL was the most 
common and the higher frequencies were the most affected. Low CD4 cell count and advanced 
HIV disease were associated with increased chance of having a hearing loss.                                                   
Conclusion: Hearing loss is more prevalent in HIV positive individuals than negative normal 
subjects and tends to worsen with the advancement of the HIV disease. This may negatively 
impact on the overall care and standard of living of HIV positive patients, hence otological care 
should be part of the comprehensive care.  
Introduction 
Over 50% of HIV infected patients present first to the otorhinolaryngologist1. Of all the 
otorhinolaryngological manifestations, otological symptoms comprise at least 62%, yet many care-
givers are unaware of these otological symptoms hence they are more likely to concentrate on other 
manifestations2, 3. Somefun et al3 looked at 98 patients at Lagos University teaching hospital and 
found that while only 17% of the patients were referred because of otorhinolaryngological (ORL) 
diseases, 80% of them actually had ORL/head and neck conditions. 
 Numerous international studies have demonstrated a relationship between HIV/AIDS and auditory 
function. Kohan et al2 conducted a 5-year retrospective study to evaluate otologic disease in patients 
with AIDS at New York university medical center- Bellevue hospital. They found that 62% had 
hearing loss 2. Marra et al4 did a case control study of 99 HIV positive patients at the university of 
Washington HIV based clinic and found that 29% of the patients had hearing loss4.  
Hearing disability compromises the overall economic productivity of an individual and may render 
one an outcast. In HIV positive patients who are still stigmatized, it can lead to marked reduction of 
quality of life. In this study, the nature and degree of hearing disability in HIV infected patients 
presenting at CCC were determined. This will raise the awareness of care-givers and eventually 
improve the quality of life and productivity of HIV/AIDS patients. 
Patients and Methods 
This was a hospital based case control study done between January and April 2007, at the 
comprehensive care clinic and voluntary counseling and testing centre. A minimum sample size of 
115 was required in each arm. The study subjects were adult HIV positive patients not on 
antiretroviral drugs aged between 18 and 50years recruited into the study from the CCC clinic 
whereas the controls were HIV negative subjects who were age and sex matched recruited from VCT 
centre. Patients who suffered diabetes, meningitis, head injury or cerebrovascular accident and those 
 




who had exposure to ototoxic medications were excluded from the study. Written informed consent 
was obtained from the subjects. Approval to carry out this study was obtained from the Ethics and 
Research committee of Kenyatta national hospital. 
A clinical history was taken followed by thorough physical examination, otoscopy and tuning folk 
tests, PTA and tympanometry. The WHO staging of the HIV disease and CD4 cell count were carried 
out in the study subjects. CD4 count was determined by the automated flow cytometry analyzer, 
FASCOUNT (benedict dick, USA). Data analysis was done using SPSS version 10.0 software and 
descriptive statistics were done. 
Results 
The study group comprised of 194 subjects who were HIV positive but not on ARVs and the control 
group were 124 subjects who were HIV negative. In the study group, males were 75 (38.7%) while 
females were 119 (61.3%). In the control group, males were 47 (37.9%) and females were 77 
(62.1%). The age and sex in both the study group and the control were similar because they were 
matched for age and sex. The age ranged from 18 yrs to 50 yrs in both the study and control groups 
with a mean age of 36.09 and 36.4 yrs respectively and the median age as 35 yrs and 36 yrs 
respectively. The mode was 37 in both groups. Most of the patients were between 32 yrs to 38 yrs old. 
As seen below (table 1), the hearing loss was 33.5% in the study group and 8.1% in the control group. 
This is statistically significant. There was no gender bias in hearing loss. 
The hearing level when computed according to age groups showed that hearing loss worsens with 
increasing age as shown in figure 1. This was statistically significant (P=0.022). 
Table 1. Hearing Loss in the Study and Control Groups. 
  Study Group Percent Control Group Percentage 
Present 65 33.5 10 8.1 HL 
Absent 129 66.5 114 91.9 
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Figure 1. Correlationship between hearing level and age in the study group. 
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Figure 2. Relationship between WHO stage and hearing level. 
 
Figure 3. Relationship between CDC stage and hearing level. 
The subjects were classified according to the WHO clinical staging for retroviral disease and the 
hearing level determined. Results indicate that hearing loss worsens as the WHO clinical stage of the 
disease advances as shown in figure 2. This was statistically significant correlation (P=0.004). The 
worsening of hearing level with advancement of the HIV disease was likewise confirmed when the 
CDC stage was correlated with the hearing level as shown in Figure 3. 
When the nature of hearing loss was assessed, it was found that 74% had SNHL, 22% CHL and 4% 
had mixed HL. As the age advances, the proportion of subjects with CHL decreases but those with 
SNHL increases as shown in figure 4 below. 
 






Figure 4. Relationship Between Age and Type of Hearing Loss. 
Dscussion 
Hearing loss is a cardinal feature and disability in HIV/AIDS patients. In this study, 33.5% of HIV 
positive patients not on ARVs had hearing level above 25 dB in at least one of the hearing frequencies 
compared to only 8.1% in HIV negative normal subjects. Soucek and Michaels5 got 39% in a sample 
size of 65 subjects and Wang et al6 got 45.5% in a sample size of 350. There is a wide variation found 
in different studies and this could be due to the sample size and the cut off decibel for hearing loss.  
It has been shown that HIV positive subjects are at a higher risk of developing a hearing loss. 
Mandela in her study of the effect of streptomycin on the cochlear found that HIV positive patients on 
streptomycin are at a higher risk of sustaining sensorineural hearing loss than HIV negative patients 
on the same treatment7. Many other drugs commonly prescribed to treat various opportunistic 
infections as well as ARVs have been implicated in causing hearing loss4,8. This study found no 
difference in the HL according to gender. In both sexes, 33.45 % had a HL. This suggests that the sex 
of the subject does not play any role in the causation of hearing loss but males are the ones who 
mostly work in noisy environments and are therefore predisposed to noise induced hearing loss, 
however, such patients were excluded from the study. 
The HL gets worse with advancement of age and this was found to be statistically significant P<0.05 
(0.022). Marra et al4 also got a similar finding. In this study, patients over 50 yrs of age were excluded 
to avoid the effects of presbyacusis since it is a known fact that as one ages, HL gradually develops 
especially after the age of 60 yrs. The elderly subjects in this study comprised the majority with HL 
compared to the younger population, this may indicate that HIV has more adverse effects on the 
hearing apparatus in the elderly population9, but this needs to be proved beyond question in a suitably 
designed study with hearing loss corrected for presbyacusis. 
The number of subjects with a HL increases with advancement in the WHO stage of the disease. This 
was statistically significant and it could be due to the effect of the HIV virus on the cochlear10, middle 
ear infections11 or CNS complications5. Patients with advanced HIV disease are more predisposed to 
infections including those that interfere with hearing. Michaels et al found that 60% had features of 
otitis media in temporal bones of patients who succumbed to HIV11. This may account for the increase 
in HL with advancement of HIV disease stage. 
 




Subjects who had HL mostly experienced SNHL (74%) followed by CHL (21.5%) and mixed HL 
(4.5%) was the least. Mild HL (26-40 dB) was the most common at 70% followed by moderate HL 
(24.5%), moderate severe HL (4.5%) and severe HL was 1%. There was no profound HL in the study 
population. This is the same trend found by Soucek5. The possible causes of HL in HIV disease could 
be divided into three, those due ototoxic drugs administered to these patients, CNS effects of the virus 
including CNS infections and tumours e.g. toxoplasmosis, meningitis, CMV, tuberculosis and 
lymphoma, and lastly the effects of the virus on the cochlear. Michaels et al found reduced 
otoacoustic emissions due to hair cell loss in temporal bones of HIV infected patients11.  
The higher frequencies i.e. 4 KHz and 8 KHz are the most affected while the middle frequencies are 
largely spared. Similar findings were gotten by Soucek5 where 6 KHz and 8 KHz were the most 
affected. This is thought to be due to changes in the cochlear mechanics5.  
Subjects with CD4 cell counts below 200/µl had the highest proportion of those with HL at 38%, 
followed by those with CD4 cell counts between 200 and 500/µl at 28% and those whose CD4 cell 
counts were above 500/µl at 22%. This means that as the CD4 cell count falls, the chance of 
developing a hearing loss increases. The absolute CD4 cell count was found to be statistically related 
to the development of a HL. Kohan and Giacchi12 found that the more immunocompromised AIDS 
patients had more advanced otologic disease. The markedly lower incidence of otitis media of 8% 
overall found clinically5 compared to that found at autopsy of 20% 11 might suggest that severe otitis 
media is a late terminal manifestation of AIDS, this supports the finding of HL being more common 
in advanced disease. 
Conclusion 
 Hearing loss is more prevalent in HIV positive individuals. This indicates that the HIV 
positive patient may not be able to follow the instructions and counseling usually given as 
part of the comprehensive care and this may negatively impact on the overall care and quality 
of life. 
 HIV-positive patients frequently do not complain of deafness until significant hearing loss has 
occurred. They usually have many symptoms and initially may perceive hearing loss as a 
relatively minor problem in comparison or may actually think it is part of the disease problem 
(13). Therefore, clinicians should deliberately seek to find out the hearing level of these 
patients in order for early and timely remedial measures especially in elderly since there is a 
strong association of HL with advancement of age. 
 There is strong association of HL and the CD4 cell count. Patients with a low CD4 cell count 
are likely to develop a hearing loss. There is also a general trend of increased prevalence of 
those with a HL with advancement in WHO stage of HIV disease.  
 SNHL is the most common type of hearing disorder in HIV positive individuals and the 
intensity of the hearing loss is mostly mild. The higher frequencies are the most affected 
followed by the lower frequencies while the middle ones are largely spared. 
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